scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0161-6420(95)30968-2 |
P698 | PubMed publication ID | 7539905 |
P2093 | author name string | Ho AC | |
Yannuzzi LA | |||
DeRosa J | |||
Pisicano K | |||
P2860 | cites work | Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results | Q33227800 |
Perifoveal laser treatment for subfoveal choroidal new vessels in age-related macular degeneration. Results of a randomized clinical trial | Q33267227 | ||
Subfoveal choroidal neovascular membranes in age-related macular degeneration. Visual prognosis in eyes with relatively good initial visual acuity | Q35042868 | ||
Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture | Q42483851 | ||
Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study. | Q43675259 | ||
Idiopathic Focal Subretinal Neovascularization | Q67459151 | ||
Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | Q67702243 | ||
Interferon alpha 2a for treatment of age-related macular degeneration | Q67960883 | ||
Retinal pigment epithelial cells release inhibitors of neovascularization | Q69006175 | ||
Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration | Q69130934 | ||
The development of neovascularization of senile disciform macular degeneration | Q69549532 | ||
Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group | Q71618226 | ||
Visual results after surgical removal of subfoveal choroidal neovascular membranes | Q71640378 | ||
Subfoveal and juxtafoveal Subretinal Neovascularization in the Presumed Ocular Histoplasmosis Syndrome | Q72380304 | ||
Follow-up Study of Presumed Ocular Histoplasmosis Syndrome | Q72614305 | ||
Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration | Q72661582 | ||
Argon laser photocoagulation for idiopathic neovascularization. Results of a randomized clinical trial | Q72711296 | ||
P433 | issue | 5 | |
P921 | main subject | neovascularization | Q1281049 |
P304 | page(s) | 782-789 | |
P577 | publication date | 1995-05-01 | |
P1433 | published in | Ophthalmology | Q7098109 |
P1476 | title | The natural history of idiopathic subfoveal choroidal neovascularization | |
P478 | volume | 102 |
Q43100454 | A case of idiopathic choroidal neovascular membrane in a young patient |
Q42360127 | Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan |
Q64091984 | Cytokine profiling reveals increased serum inflammatory cytokines in idiopathic choroidal neovascularization |
Q99726348 | Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration |
Q47836487 | Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization |
Q42475184 | Evaluation of Idiopathic Choroidal Neovascularization with Indocyanine Green Angiography in Patients Undergoing Bevacizumab Therapy |
Q30845407 | Identification of ingrowth site of idiopathic subfoveal choroidal neovascularization by indocyanine green angiography |
Q37202359 | Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment |
Q33993740 | Idiopathic choroidal neovascular membrane in a young female |
Q42430430 | Idiopathic choroidal neovascularisation as the inaugural sign of multiple evanescent white dot syndrome |
Q51630122 | Idiopathic choroidal neovascularisation in pregnancy: treatment options and a successful outcome. |
Q74820118 | Indocyanine green angiographic features of idiopathic submacular choroidal neovascularization |
Q73496540 | Indocyanine green angiographic findings in idiopathic choroidal neovascularisation |
Q73251142 | Indocyanine green angiographic findings in idiopathic choroidal neovascularization |
Q33750476 | Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor |
Q31857804 | Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration |
Q38265318 | Intravitreal bevacizumab as a primary treatment for idiopathic choroidal neovascularization |
Q37574937 | Intravitreal bevacizumab for choroidal neovascularisation secondary to causes other than age-related macular degeneration. |
Q36050969 | Intravitreal bevacizumab for choroidal neovascularization secondary to non-age-related macular degeneration |
Q46823342 | Massive haemorrhagic retinal detachment after transpupillary thermotherapy for choroidal neovascularisation |
Q55452008 | Multispectral imaging in detecting early retinal pigment epithelial atrophy. |
Q73314196 | Optical coherence tomographic features of idiopathic submacular choroidal neovascularization |
Q36601736 | Optical coherence tomography characteristics of responses to intravitreal bevacizumab in idiopathic choroidal neovascularization |
Q36444569 | Photodynamic therapy in macular diseases of asian populations: when East meets West |
Q44516148 | Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults |
Q46802970 | Photodynamic therapy of idiopathic subfoveal choroidal neovascularization in Taiwanese patients: a 2-year follow-up |
Q44673688 | Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series. |
Q35953670 | Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation |
Q84607146 | Serum Inflammatory Factors in Patients with Idiopathic Choroidal Neovascularization |
Q35040924 | Slow progression of exudative age related macular degeneration associated with hypertrophy of the retinal pigment epithelium |
Q58600435 | Statement of the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular degeneration : Dated Ocotber 2017 |
Q74591971 | Surgical removal of non-age-related subfoveal choroidal neovascular membranes |
Q31993113 | The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. |
Q42410184 | The use of systemic steroids and photodynamic treatment for choroidal neovascularisation in young patients |
Q44049073 | Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin |
Q35953657 | Two-year results of surgical removal of choroidal neovascular membranes related to non-age-related macular degeneration |
Q88008485 | [Statement from the BVA, the DOG, and the RG on treatment of choroidal neovascularization in diseases other than neovascular age-related macular degeneration : October 2017] |
Search more.